30th Apr 2009 16:01
RNS Number : 5227R
Ark Therapeutics Group PLC
30 April 2009
30 April 2009
Ark Therapeutics Group plc
Voting Rights and Capital
In accordance with the FSA's Disclosure and Transparency Rules, Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") confirms that as at the date of this announcement the Company's issued share capital consists of 207,116,751 ordinary shares with voting rights. The Company does not hold any shares in Treasury.
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to the interest in, Ark under the FSA's Disclosure and Transparency Rules.
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
PVG.L